Retrogenix | Welcome

Retrogenix provides the leading solution for discovering which human plasma membrane proteins are targeted by antibodies, proteins, small molecules and viruses.

Retrogenix identifies on behalf of its clients:
  • New, disease-relevant drug targets
  • Previously unknown cell surface receptors to protein ligands and viruses
  • Secondary targets, to assist decision-making and avoid toxicities
This is achieved by screening our clients’ molecules against the most comprehensive set of human plasma membrane proteins available in the context of the human cell. Now covering more than 3500 proteins, this represents the majority of known plasma membrane proteins.

Retrogenix has a rich client portfolio, including many global pharmaceutical / drug discovery companies and academic institutions. We give our commercial clients a competitive advantage by identifying high quality, unexploited drug targets, and helping them to improve success rates at all stages of the drug research and development process.

Latest News

Biotechnology company Retrogenix is pleased to announce an extension to its collaboration with Swedish-based antibody pharmaceutical company BioInvent International AB... | Read More

Events

Retrogenix will soon be attending PEGS and the Pharma-Bio Partnering Forum, Boston, USA (29th April to May 3rd, 2013) | Find out more

Testimonials

“We are very happy with our collaboration with Retrogenix, and how their platform has delivered.”  | Read more
Björn Frendéus, Vice President of Pre-clinical Research at BioInvent.